# Rozerem

NDC: 64764-805
Generic name: ramelteon
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20050722

FDA application: NDA021782

## Active ingredients

- RAMELTEON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-805"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-805
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9de82310-70e8-47b9-b1fc-6c6848b99455